An antibody against non-muscle beta-actin is superior to phalloidin for monitoring the actin cytoskeleton in rat cardiac capillary endothelial cells.
Antibody offers endothelial actin specificity in rat models; leaves open translation to human microvascular studies.
OBJECTIVE: Active constriction in cardiac capillary endothelial cells (CCECs) is controversial. It is thought by many researchers that CCECs are not actively involved in constriction; others believe that these cells do contribute some of the force required for capillary constriction. Because actin is a major component of most contractile mechanisms responsible for changing cell shape, we compared two probes as potential monitors of actin distribution in CCECs in situ. METHODS: We used SDS-PAGE, Western blotting, electron microscopy, conventional epifluorescence and confocal microscopy to evaluate an antibody against non-muscle beta-actin and fluorescently labeled phalloidin to detect actin in CCECs. RESULTS: Fluorescently labeled phalloidin detected actin in cardiac muscle and faintly in CCECs. The antibody probe detected non-muscle beta-actin CCECs. However, this actin isotype did not occur in cardiac myocytes. In endothelial cells non-muscle beta-actin was concentrated at the cell periphery, and arranged as bundles of fibers, not as typical stress fibers. CONCLUSIONS: Phalloidin is not suitable as a probe to monitor actin distribution in CCEC's in situ. The antibody is a potentially useful tool in monitoring the actin cytoskeleton and determining the capacity of CCECs for active vasoconstriction in vivo. Non-muscle beta-actin in CCECs is arranged in filament bundles which are not typical stress fibers.
No takes yet. Share an insight, caveat, or question.
Glyn et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: